Similar sites
Category
ChemistryGlobal Rank
N/ARank in 1 month
8.9KEstimate Value
N/A
#life science
#bruker topspin
#research
#optics
#analytical
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/ASorry. Description is not currently available
#møller bil
#skoda kokstad
#bruktbil
#bil salg
#møller
#eff tdi 2020
#9rayti f click
#eff 2020 tdi
#eff tdm
#eff tdi
#skoda enyaq
#skoda city go
#audi e tron
#passat gte 2018
#bilhold
#møller bil trondheim
#vinterdekk bytte
#www.møller bil.no/ski
#enyaq iv 80x
#skoda larvik
#kjøpe bruktbil
#autodb
Malware Scan Info
Macafee Check : 
Email address with brukinsa.com
Recent Searched Sites
Crdo.bsuir.by (1 mins ago) / BY
Stakehosting.com (6 seconds ago) / US
B-hotel-stuttgart-city.hotelmix.fr (2 mins ago) / US
Soccer.sincsports.com (29 seconds ago) / US
Ten-dots.com (10 seconds ago) / US
Recipesforholidays.com (3 mins ago) / US
Courses.homesteadrabbits.com (1 mins ago) / US
Ourmineralresource.org (6 seconds ago) / US
Fccasa.jp (9 seconds ago) / JP
Seipi.org.ph (5 seconds ago) / ID
Uj-tours.com (15 seconds ago) / JP
Texaspayflex.com (10 seconds ago) / US
The-beechfield-hotel-blackpool.hotelmix.co.uk (18 seconds ago) / US
Msconnections.ca (1 mins ago) / US
Foodtechaccelerator.io (10 seconds ago) / US
4lapki.com (16 seconds ago) / RU
Nathanblasac.com (7 seconds ago) / US
Brukinsa.com (0 seconds ago) / US
Sonicmediatv.com (34 seconds ago) / US
Re-cult.ru (7 seconds ago) / US
Domain Informations
Brukinsa.com lookup results from whois.registrar.amazon.com server:
- Domain created: 2017-09-13T13:19:33Z
- Domain updated: 2024-08-09T22:48:00Z
- Domain expires: 2025-09-13T13:19:33Z 0 Years, 352 Days left
- Website age: 7 Years, 13 Days
- Registrar Domain ID: 2162427762_DOMAIN_COM-VRSN
- Registrar Url: http://registrar.amazon.com
- Registrar WHOIS Server: whois.registrar.amazon.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +1.2024422253
- Name server:
- NS-1051.AWSDNS-03.ORG
- NS-1976.AWSDNS-55.CO.UK
- NS-223.AWSDNS-27.COM
- NS-747.AWSDNS-29.NET
Network
- inetnum : 3.208.0.0 - 3.223.255.255
- name : AMAZON-IAD
- handle : NET-3-208-0-0-1
- status : Reallocated
- created : 2018-04-25
- changed : 2019-08-02
Owner
- organization : Amazon Data Services NoVa
- handle : ADSN-1
- address : Array,Herndon,VA,20171,US
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 682459 |
| namecheap.com | 226280 |
| networksolutions.com | 167026 |
| tucows.com | 138054 |
| publicdomainregistry.com | 86591 |
| whois.godaddy.com | 62081 |
| enomdomains.com | 58049 |
| cloudflare.com | 51575 |
| namesilo.com | 48435 |
| gmo.jp | 46514 |
| register.com | 38825 |
| fastdomain.com | 38013 |
| ionos.com | 33965 |
| wildwestdomains.com | 32128 |
| name.com | 31938 |
| registrar.amazon.com | 30730 |
| net.cn | 30663 |
| dynadot.com | 28794 |
| key-systems.net | 27094 |
Host Informations
| Host name | ec2-3-221-172-193.compute-1.amazonaws.com |
| IP address | 3.221.172.193 |
| Location | Ashburn United States |
| Latitude | 39.0481 |
| Longitude | -77.4728 |
| Metro Code | 511 |
| Timezone | America/New_York |
| Postal | 20149 |
Port Scanner (IP: 3.221.172.193)
Spam Check (IP: 3.221.172.193) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Websites Listing
We found Websites Listing below when search with brukinsa.com on Search Engine
Brukinsa: Uses, side effects, interactions, and more
Brukinsa is a Bruton’s tyrosine kinase (BTK) inhibitor. It forms a covalent bond in the BTK active site and leads to inhibition of BTK activity. This leads to inhibition of cell signaling ...
Medicalnewstoday.comDA: 24 PA: 18 MOZ Rank: 42
brukinsa photos on Flickr | Flickr
Brukinsa là một loại thuốc kê đơn có thương hiệu được chấp thuận để điều trị ung thư hạch tế bào mantel (MCL) ở người lớn. MCL là một loại ung thư máu. Thuốc này được FDA chấp thuận để sử dụng cho những người đã sử dụng ít nhất một phương pháp điều trị …
Flickr.comDA: 14 PA: 22 MOZ Rank: 37
Brukinsa oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
Brukinsa 80 Mg Capsule Antineoplastic - Protein-Tyrosine Kinase Inhibitors - Uses, Side Effects, and More Generic Name: zanubrutinib . This medication is …
Webmd.comDA: 13 PA: 42 MOZ Rank: 57
BeiGene Presents Results from SEQUOIA Trial of BRUKINSA …
These patients will receive BRUKINSA treatment at 160 mg twice daily for three months, followed by combination treatment of BRUKINSA at the same dosing and venetoclax with a ramp-up dosing to 400 ...
Businesswire.comDA: 20 PA: 50 MOZ Rank: 47
Available information for BRUKINSA - Submission control number …
BRUKINSA Manufacturer: BEIGENE SWITZERLAND GMBH Ingredients: ZANUBRUTINIB; Health Canada regulatory activity: NDS Health Canada regulatory decision: NOC Health Canada regulatory decision date: 2021-07-22 Health Canada public release date: 2021-10-15. Submission archive. Download ZIP (45.37 MB) Study documents . 1.0.7 General Note to Reviewer. …
Clinical-information.canada.caDA: 30 PA: 18 MOZ Rank: 52
IRC Determines BRUKINSA® (Zanubrutinib) Demonstrates …
BRUKINSA is supported by a broad clinical program which includes more than 3,900 subjects in 35 trials across 28 markets. To date, BRUKINSA has received more than 20 approvals covering more than ...
Businesswire.comDA: 20 PA: 50 MOZ Rank: 45
Brukinsa (zanubrutinib) for the Treatment of Waldenstrom’s ...
Brukinsa is a small-molecule, orally active BTK inhibitor that covalently binds with a cysteine residue in the BTK’s active site, inactivating the enzyme irreversibly and inhibiting BTK activity. BTK is an essential component of the B-cell receptor (BCR) signalling pathways. The BCR signalling controls cell proliferation and survival in ...
Clinicaltrialsarena.comDA: 27 PA: 50 MOZ Rank: 97
Zanubrutinib - Wikipedia
Zanubrutinib, sold under the brand name Brukinsa, is a medication used for the treatment of mantle cell lymphoma (MCL), Waldenström's macroglobulinemia (WM), and marginal zone lymphoma (MZL). Zanubrutinib is classified as a Bruton's tyrosine kinase (BTK) inhibitor. It is given by mouth.. It was approved for medical use in the United States in November 2019.
En.wikipedia.orgDA: 16 PA: 18 MOZ Rank: 41
Brukinsa - DKP Scout
This information may not be consistent with the current Brukinsa™ (zanubrutinib) prescribing information, is not intended as an endorsement and makes no representations regarding any usage, which is inconsistent with the FDA-approved prescribing information. Agree Would you like to continue? You are now leaving BeiGene's Payer Interactive Map Website. Would you like to …
Dkpscout.comDA: 12 PA: 24 MOZ Rank: 44
BeiGene Announces BRUKINSA (zanubrutinib) Approval in …
BRUKINSA is supported by a broad clinical program which includes more than 3,900 subjects in 35 trials across 28 markets. To date, BRUKINSA has received more than 20 approvals covering more than ...
Finance.yahoo.comDA: 17 PA: 50 MOZ Rank: 95
FDA Approves Beigene’s Brukinsa to Treat Waldenström’s ...
Brukinsa (zanubrutinib) is a small molecule inhibitor of Bruton’s tyrosine kinase (BTK) discovered by BeiGene scientists that is currently being evaluated globally in a broad clinical program as a monotherapy and in combination with other therapies to treat various B-cell malignancies. Because new BTK is continuously synthesized, Brukinsa was specifically …
Globalgenes.orgDA: 15 PA: 50 MOZ Rank: 40
[Product Monograph Template - Standard]
BRUKINSA can cause harm to the developing fetus and loss of pregnancy (See 7.1.1 Pregnant Women). Advise women of the potential hazard to a fetus and to avoid becoming pregnant during treatment and for at least 1 week after the last dose of BRUKINSA. Pregnancy testing is recommended for females of reproductive potential prior to initiating BRUKINSA. Advise men …
Pdf.hres.caDA: 11 PA: 20 MOZ Rank: 42
BeiGene Announces BRUKINSA® (Zanubrutinib) Approved for …
About BRUKINSA ® (zanubrutinib) BRUKINSA is a small molecule inhibitor of Bruton’s tyrosine kinase (BTK) discovered by BeiGene scientists that is currently being evaluated globally in a broad clinical program as a monotherapy and in combination with other therapies to treat various B-cell malignancies. Because new BTK is continuously ...
Ca.finance.yahoo.comDA: 20 PA: 50 MOZ Rank: 38
2022-04-28 | NDAQ:BGNE | Press Release | BeiGene Ltd.
BRUKINSA is a small molecule inhibitor of Bruton’s tyrosine kinase (BTK) discovered by BeiGene scientists that is currently being evaluated globally in a broad clinical program as a monotherapy and in combination with other therapies to treat various B-cell malignancies. Because new BTK is continuously synthesized, BRUKINSA was specifically ...
Stockhouse.comDA: 14 PA: 50 MOZ Rank: 37
Brukinsa capsule 80mg | Brunet
Take advantage of discounts on select beauty products and get advice from cosmetics professionals.
Brunet.caDA: 13 PA: 50 MOZ Rank: 91
BRUKINSA® (Zanubrutinib) Demonstrates Superior Objective
BRUKINSA is a small molecule inhibitor of Bruton’s tyrosine kinase (BTK) discovered by BeiGene scientists that is currently being evaluated globally in a broad clinical program as a monotherapy and in combination with other therapies to treat various B-cell malignancies. Because new BTK is continuously synthesized, BRUKINSA was specifically …
Ca.finance.yahoo.comDA: 20 PA: 50 MOZ Rank: 35
BeiGene Announces Authorisation of BRUKINSA (zanubrutinib) …
BRUKINSA (zanubrutinib) is a small molecule inhibitor of Bruton’s tyrosine kinase (BTK) discovered by BeiGene scientists that is currently being evaluated globally in a broad clinical program as a monotherapy and in combination with other agents to treat various B-cell malignancies. Because new BTK is continuously synthesized, BRUKINSA was specifically …
Marketscreener.comDA: 22 PA: 50 MOZ Rank: 34
BeiGene Announces Approval in Canada of BRUKINSA® …
About BRUKINSA ® (zanubrutinib) BRUKINSA is a small molecule inhibitor of Bruton’s tyrosine kinase (BTK) discovered by BeiGene scientists that is currently being evaluated globally in a broad clinical program as a monotherapy and in combination with other therapies to treat various B-cell malignancies. Because new BTK is continuously synthesized, BRUKINSA …
Financialpost.comDA: 17 PA: 50 MOZ Rank: 33
BeiGene Reports Fourth Quarter and Full Year 2021 Financial Results
– Global sales of BRUKINSA of $87.6 million and $218.0 million for the fourth quarter and full year 2021, respectively, compared to $18.3 million and $41.7 million in the prior year periods. Full year 2020 revenue from BRUKINSA reflects sales since its launch in China in June 2020, as well as sales in the United States for the full year;
Biospace.comDA: 16 PA: 50 MOZ Rank: 32
Stock Market | FinancialContent Business Page
About BRUKINSA. BRUKINSA is a small molecule inhibitor of Bruton’s tyrosine kinase (BTK) discovered by BeiGene scientists that is currently being evaluated globally in a broad clinical program as a monotherapy and in combination with other therapies to treat various B-cell malignancies. Because new BTK is continuously synthesized, BRUKINSA ...
Markets.financialcontent.comDA: 28 PA: 50 MOZ Rank: 31
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| 0505dy.org | namecheap.com | 259 Days |
| genode.org | united-domains.de | 126 Days |
| green-horizons.org | enom.com | 224 Days |
| aruliyacare.com | godaddy.com | 12 Days |
| scaungaming.com | openprovider.com | 169 Days |
| vbriceland.com | networksolutions.com | 1 Year, 47 Days |